Literature DB >> 20632153

Tick-borne encephalitis and golden agers: position paper of the International Scientific Working Group on Tick-borne encephalitis (ISW-TBE).

Zsuzsanna Jelenik1, Michael Keller, Benjamin Briggs, Göran Günther, Mats Haglund, Henrieta Hudeckova, Eva Jilkova, Aukse Mickiene, Birger Sandell, Robert Steffen, Franz Strle.   

Abstract

One of the primary goals of the 11th Annual Meeting of the International Scientific Working Group on Tick-borne encephalitis (ISW-TBE) held in 2009 was to develop the first update of the Position Paper on TBE in Golden Agers, summarizing the most essential aspects of the disease in this age group. TBE morbidity has continued to increase in recent years, which is thought to be due to an interplay of social, political, ecological, economic and demographic factors combined with climate changes. Today's golden agers i.e. individuals aged 50 years or above, are healthier and more mobile, lead more active lifestyles and spend more time travelling and performing outdoor leisure activities. This places them at an increased risk of infection. At the same time, increasing age is associated with a quantitative and qualitative decline in innate and adaptive immunity, which is why elderly individuals are more susceptible to infection and severe disease than younger people. Also, their response to vaccination tends to be slower, antibody titres generally reach lower levels and titres tend to decrease earlier than in younger individuals. Evidence is accumulating that this is also the case with TBE vaccination, emphasizing the importance of administering the first TBE booster vaccination no later than 3 years after the completion of primary immunization or at an even shorter interval. Encouragingly, recent data have shown that the field effectiveness of TBE vaccination exceeds 97%, with no significant differences between age groups.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20632153     DOI: 10.1007/s10354-010-0758-5

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  29 in total

1.  Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.

Authors:  Alexandra Loew-Baselli; Eva-Maria Poellabauer; Borislava G Pavlova; Sandor Fritsch; Manuela Koska; Roman Bobrovsky; Ryszard Konior; Hartmut J Ehrlich
Journal:  Hum Vaccin       Date:  2009-08

Review 2.  Tick-borne encephalitis--pathogenesis, clinical course and long-term follow-up.

Authors:  Mats Haglund; Göran Günther
Journal:  Vaccine       Date:  2003-04-01       Impact factor: 3.641

Review 3.  A 10-year follow-up study of tick-borne encephalitis in the Stockholm area and a review of the literature: need for a vaccination strategy.

Authors:  M Haglund; M Forsgren; G Lindh; L Lindquist
Journal:  Scand J Infect Dis       Date:  1996

4.  Tickborne encephalitis in an area of high endemicity in lithuania: disease severity and long-term prognosis.

Authors:  Aukse Mickiene; Alvydas Laiskonis; Göran Günther; Sirkka Vene; Ake Lundkvist; Lars Lindquist
Journal:  Clin Infect Dis       Date:  2002-08-20       Impact factor: 9.079

Review 5.  Tick-borne encephalitis in Europe and beyond--the epidemiological situation as of 2007.

Authors:  J Suss
Journal:  Euro Surveill       Date:  2008-06-26

6.  Tick-borne encephalitis: from epidemiology to vaccination recommendations in 2007. New issues--best practices.

Authors:  Ursula Kunze
Journal:  Wien Med Wochenschr       Date:  2007

Review 7.  Tick-borne encephalitis incidence in Central and Eastern Europe: consequences of political transition.

Authors:  Sarah E Randolph
Journal:  Microbes Infect       Date:  2007-12-23       Impact factor: 2.700

Review 8.  Socio-economic factors in the differential upsurge of tick-borne encephalitis in Central and Eastern Europe.

Authors:  Dana Sumilo; Antra Bormane; Loreta Asokliene; Veera Vasilenko; Irina Golovljova; Tatjana Avsic-Zupanc; Zdenek Hubalek; Sarah E Randolph
Journal:  Rev Med Virol       Date:  2008 Mar-Apr       Impact factor: 6.989

Review 9.  Vaccines for preventing tick-borne encephalitis.

Authors:  Vittorio Demicheli; Maria Grazia Debalini; Alessandro Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

10.  Climate change cannot explain the upsurge of tick-borne encephalitis in the Baltics.

Authors:  Dana Sumilo; Loreta Asokliene; Antra Bormane; Veera Vasilenko; Irina Golovljova; Sarah E Randolph
Journal:  PLoS One       Date:  2007-06-06       Impact factor: 3.240

View more
  2 in total

Review 1.  [Vaccination in advanced age].

Authors:  H J Heppner; A Leischker; P Wutzler; A Kwetkat
Journal:  Internist (Berl)       Date:  2018-02       Impact factor: 0.743

2.  Quantitative evaluation of the severity of acute illness in adult patients with tick-borne encephalitis.

Authors:  Petra Bogovic; Mateja Logar; Tatjana Avsic-Zupanc; Franc Strle; Stanka Lotric-Furlan
Journal:  Biomed Res Int       Date:  2014-05-07       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.